Metformin Hydrochloride
NDC Package 65841-030-01
Package Information
Metformin Hydrochloride is tablet is indicated as an adjunct to diet and exercise to improve glycemic control in adults and children with type 2 diabetes mellitus. Marketed by Cadila Healthcare Limited, this product is identified by NDC 65841-030 and is authorized under FDA application ANDA077064.
Identification & Billing
- RxCUI: 861004 - metFORMIN HCl 1000 MG Oral Tablet
- RxCUI: 861004 - metformin hydrochloride 1000 MG Oral Tablet
- RxCUI: 861004 - metformin HCl 1 GM Oral Tablet
- RxCUI: 861007 - metFORMIN HCl 500 MG Oral Tablet
- RxCUI: 861007 - metformin hydrochloride 500 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 65841 - Cadila Healthcare Limited
- 65841-030 - Metformin Hydrochloride
- 65841-030-01 - 100 TABLET, FILM COATED in 1 BOTTLE
- 65841-030 - Metformin Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (65841-030). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 65841-030-01 identifies a specific commercial package of 100 tablet, film coated in 1 bottle of Metformin Hydrochloride, labeled by Cadila Healthcare Limited. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Cadila Healthcare Limited on March 20, 2010. The current certification is valid through December 31, 2024.
How is this Cadila Healthcare Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 65841003001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.